Opinion
|
Pfizer and Wyeth
So, Pfizer wants to merge with Wyeth? Sensible move... or a wild lurch from a desperate giant, keen to use size as its only available strategy? Thoughts please!
So, Pfizer wants to merge with Wyeth? Sensible move... or a wild lurch from a desperate giant, keen to use size as its only available strategy?
Thoughts please!
blog comments powered by Disqus
Printer-friendly version
Send to friendMost Popular This Month
Featured Articles
-
Pharma marketing research and Web 2.0
Andrew Tolve investigates the value of the Internet as a pharma marketing research medium
-
Pharma a leader in web effectiveness
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
-
Market access: Pharma and the definition of value
Jan Stojaspal explores the role of value-based pricing in gaining market access
Upcoming Events
View All Events-
May 29, 2012 - May 30, 2012London, UK
-
Jun 12, 2012 - Jun 14, 2012Somerset, NJ
-
Jun 13, 2012 - Jun 14, 2012Somerset, NJ
recent Comments
Latest Podcasts
Pharma, social media and data analytics
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
"Speed and Usability are Key" - insights from Boehringer Ingelheim
An interview with Serkan Erkovan of Boehringer Ingelheim.
Podcast: "Build KOL trust" - insights from Pediapharm
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs
Upcoming Events
View All Events-
May 24, 2012 - May 25, 2012Toronto, Canada
-
Jun 28, 2012 - Jun 29, 2012Miami, USA
-
Jun 28, 2012 - Jun 29, 2012Miami, USA
-
September 2012Sydney, Australia
-
October 2012TBC
-
October 2012Boston, USA
-
Oct 16, 2012 - Oct 17, 2012Boston, USA